As an executive in the biopharmaceutical industry, Louis Bianco draws on expertise in strategic development and business restructuring as well as the optimization of resources. Working as a key member of the strategic management team, he assisted in reassessing portfolio priorities that then led to a 72 percent decrease in operational expenses. In addition, he has evaluated multiple acquisition opportunities, some of which worked out to provide a high return on investment for the company. Additionally, drawing on his background as a financial expert as recognized by NASDAQ, he has worked on 70+ equity/ debt offerings and debt restructures.
Louis Bianco has a master of business administration degree from the Stern School of Business at New York University, where he focused on finance and accounting. He earned a bachelor of arts in economics from Iona College.
After completing his higher education, Louis Bianco served with such financial services institutions as Deloitte & Touche, Goldman Sachs, and Deutsche Bank. He transitioned into biopharmaceutical services in 1991 as cofounder of CTI Biopharma, which he led as executive vice president of finance and administration through early 2017.